Found: 17
Select item for more details and to access through your institution.
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. E204, doi. 10.1002/ajh.26960
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1033, doi. 10.1634/theoncologist.2017-0597
- By:
- Publication type:
- Article
Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 8, p. 598, doi. 10.1002/ajh.20665
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 6, p. 502, doi. 10.1111/j.1600-0609.2010.01527.x
- By:
- Publication type:
- Article
Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 1, p. 53, doi. 10.1111/j.1600-0609.2007.00861.x
- By:
- Publication type:
- Article
End of induction [<sup>18</sup>F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 11, p. 3311, doi. 10.1007/s00259-024-06765-z
- By:
- Publication type:
- Article
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2044
- By:
- Publication type:
- Article
Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 378, doi. 10.1111/bjh.17519
- By:
- Publication type:
- Article
Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 662, doi. 10.1111/bjh.13429
- By:
- Publication type:
- Article
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 207, doi. 10.1111/bjh.12120
- By:
- Publication type:
- Article
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 10, p. 2547, doi. 10.1007/s00277-021-04604-x
- By:
- Publication type:
- Article
Amyloid in bone marrow smears of patients affected by multiple myeloma.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 5, p. 469, doi. 10.1007/s00277-009-0857-9
- By:
- Publication type:
- Article
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3290
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
- By:
- Publication type:
- Article
Incidence of fibroblastic sleeve and of catheter-related venous thrombosis in peripherally inserted central catheters: A prospective study on oncological and hematological patients.
- Published in:
- Journal of Vascular Access, 2021, v. 22, n. 3, p. 444, doi. 10.1177/1129729820949411
- By:
- Publication type:
- Article